Navigation Links
National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
Date:11/14/2012

COLUMBUS, Ohio, Nov. 14, 2012 /PRNewswire-USNewswire/ -- The National Patient Advocate Foundation (NPAF) voiced strong support for the Oral Chemotherapy Legislation (SB194) at a hearing before the Senate, Commerce and Labor Committee yesterday.  The bill ensures equity for patient out-of-pocket costs for oral and intravenous (IV) chemotherapy anti-cancer medications and protects patients by ensuring they receive their IV chemotherapy in a safe manner.

While chemotherapy has traditionally been provided through intravenous treatments, new cancer care medications are available that allow patients to administer them orally, improving patient quality of life and reducing avoidable hospital visits.  Unfortunately, these new medications often come at an extremely high cost to the patient, limiting patient access and burdening patients will financially-crippling expenses that are not currently covered under insurance plan prescription drug benefits.

Kathleen Werling, a two-time cancer survivor currently undergoing treatment for Stage IV Malignant Melanoma, spoke at yesterday's hearing in support of the legislation based on her personal experiences with high out-of-pocket costs for her IV treatment that devastated her family financially.  "We had already incurred hundreds of thousands of dollars in medical debt from the first diagnosis of my Melanoma due to it being a pre-existing condition. We had drained our college funds of six children, along with our retirement fund.  We were living day to day, paycheck to paycheck," Werling stated. "So you can understand our devastation."

NPAF strongly believes that all anti-cancer medications should be offered to patients at equitable prices.  In a letter to the Committee Chairman Kevin Bacon, NPAF states, "SB194 would make it easier for patients to afford oral and anti-cancer medications, and would also provide patients across Ohio with a higher quality of life.  For these reasons, the National Patient Advocate Foundation is pleased to support this bill."

"I see firsthand the impact and struggle patients face when they are making decisions about whether or not they can afford their medications," stated Lisa Miller, a patient advocate at a large cancer center in central Ohio and NPAF Elite Council volunteer. "Imagine how hard it would be knowing you could be one or two treatments away from a cure and not have the ability to obtain the treatment because it is not covered or the out-of-pocket expense is astronomical."

Added Miller, "I am asking you on behalf of all constituents in Ohio to pass this bill and give patients the affordable option for oral anti-cancer medications.  It's the right thing to do."


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
6. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
(Date:4/27/2016)...   , Total Sales Grow ... Clinical sales grow 16% year-over-year  , ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... ended March 31, 2016 and provided an update on ... First Quarter 2016 Revenue Results by Category  ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of non-medical in-home ... – its San Antonio West location. Prior to entering the senior care industry, Amada ... opening of Amada San Antonio West will take place on Friday, April 29th. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the development of miniature microphones and headsets announced today that the US Patent ... of integrating in-earphones into a structure. This innovative design creates a lightweight and ...
(Date:4/28/2016)... ... , ... Metabolic Nutrition today announced the upcoming launch of its ... Get Fit and Sports Expo in Orlando, Florida. Attended by pro athletes, ... 29-30, was selected as the perfect event to introduce the highly anticipated GlycoLoad. ...
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in ... has established an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and ... effective October 1, 2016. , Sarcopenia is defined as a combination of low muscle ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... to those affected by a health insurance co-operative bankruptcy to receive their ... individuals can receive over 1,500 FDA-approved prescription medications from over 180 American ...
Breaking Medicine News(10 mins):